Tidepool provides a platform for diabetes data management and integration, allowing users to upload and share data from various medical devices and applications, thereby facilitating diabetes care.

Tidepool

Tidepool | 12,355 followers on LinkedIn. Making diabetes data more accessible, meaningful, and actionable. Learn more about Tidepool Loop at tidepool.org/loop. | Tidepool is a 501(c)3 nonprofit organization dedicated to making diabetes data more accessible, actionable, and meaningful for people with diabetes, their care teams, and researchers through our open source software which includes: Tidepool Web, Tidepool Uploader, and Tidepool Mobile. Tidepool Loop is a project to build and support an FDA-regulated version of Loop, to be available in the OS App Store, intended to work with commercially available insulin pumps and CGMs. Tidepool Loop is not currently available for use.

Howard Look

VP Engineering at Tidepool.org

Tapani Otala

Redefining the status quo through innovation and collaboration.

Brandon Arbiter

Marketing Strategist for Medical Devices and Software Technology

Melissa Maniscalco

Tidepool has always been about community-driven innovation in diabetes care. To keep pushing the boundaries of what’s possible, we need your support. Here are 10 ways to get involved - from making a donation to spreading the word about our resources or getting a peek behind the scenes by supporting our user research. 🔍 Join us in championing community-first solutions and let’s make a difference together! 🤝💙 👉 Donate today: https://bit.ly/4hMSi8r

Exciting Update! 👀 Have you ever wondered if your settings adjustments made things better or worse? Well, we’ve got great news. 🎉 DIY Loopers, and their care teams, can now view their current and past therapy settings as well as other important data points that were previously not visible in the Tidepool Data Platform. This makes it easier to gain better insights from your data and make more informed decisions. 💡 #diabetesdata #loop #betterinsights #Tidepool +

We’re thrilled to announce our collaboration with Abbott to enable seamless data integration with the FreeStyle Libre portfolio in the U.S. We’re excited for this expansion of patient choice and streamlined diabetes care workflows for clinics and health systems. Check out the full press release here: https://lnkd.in/geZYXzsY

We are excited to share that Tidepool has received the DiMe Seal from the Digital Medicine Society (DiMe) for both of our software solutions, Tidepool+ and Tidepool Loop! 🙌 This recognition highlights our commitment to building digital health software that is trusted, secure, and accessible. As a known innovator in diabetes software, making diabetes data more accessible, actionable, and meaningful, we are proud to join a wider community of change-makers leading the way in healthcare. You can learn more about the DiMe Seal here: https://bit.ly/3BTXkj8 #healthcareinnovation #digitalhealth #diabetescare

So excited to see Tidepool featured by Fierce Pharma 🎉 We’re proud to be making strides in digital health #technology with our FDA-cleared software, helping people with #diabetes better manage their care. Check out the article to learn how we're changing the game! https://bit.ly/3XCmyLc

Join some of the Tidepool team at the inaugural ADEPT Health Equity Conference happening November 12-13th in Chicago! 🎉 This groundbreaking event is about "“Achieving Diabetes Equity in Practice Today” through collective learning. We're thrilled to connect with passionate leaders and explore innovative ways to create more inclusive health solutions. #ADEPT2024 #HealthEquity #TidepoolOnTheRoad Register today: https://t1dx.co/DID_ADEPT

📚 The next case study in our regulatory case study series highlights Tidepool Tidepool. This nonprofit transformed a patient-driven automated insulin dosing app into the first FDA -cleared, fully interoperable solution! 🔧 Many patients with insulin-dependent diabetes have resorted to creating DIY solutions out of frustration with existing diabetes tech limitations. Without regulated guidance, these solutions raise safety concerns. Tidepool led the charge to develop a regulated alternative focused on interoperability and patient choice. 🚀 Through early engagement, Tidepool embarked on an expedited pathway with the FDA, allowing an independent review of interoperable components. This early engagement streamlined Tidepool’s pathway to 510(k) regulatory clearance, providing more choices for the diabetes community. 🌟 Learn more about Tidepool’s innovative journey and regulatory strategy: Full Case Study 📖 View all 10 case studies to learn more about navigating the regulatory environment to bring DHTs to market: https://bit.ly/3WWdf90

Digital Medicine Society (DiMe)

Empathy-driven innovation - balancing the need to be more efficient and accessible, while remaining deeply attuned to the needs of those you serve. But how do you find time to focus on patient experience, when the world seems to change every day? This past week, we had the absolute honor to host an enlightening Digital Health Summit at MATTER HQ in Chicago, bringing together industry leaders from Advocate Health , Froedtert Health , Tidepool and Pixel Health . The focus? Merging excellent care delivery with exceptional service. The consensus was clear: healthcare must pivot from merely providing care to delivering outstanding service experiences, emphasizing patient-centered design and what to do in the wake of recent retail health events. Ensuring every patient interaction is not just functional but truly remarkable. Thank you to Jamey Shiels, Erin DeJarlais, PT, MBA, DPT , Edward Mitchell, MBA , Christian Lagier , Izzy Goodwin, MBA , Jennifer Moore and Tom S. Lee and our own Laurance Stuntz and Aaron Sheedy for the great conversation! Join us as we continue to transform healthcare through innovation and empathy. #DigitalHealth #PatientExperience #HealthcareInnovation #XealthSummit https://lnkd.in/gx97brjR

Xealth

The Digital Medicine Society (DiMe) has built out a set of new industry case studies illustrating how organizations have engaged with the FDA to successfully navigate the regulatory landscape and gain the appropriate authorization to bring their products to market - including a great narrative on how Tidepool successfully championed Tidepool Loop!

Very happy to see a topic close to my heart getting more attention! The impact of the menstrual cycle on insulin sensitivity in women with Type 1 diabetes is scientifically neglected and often overlooked. Excited about our collaboration with Tidepool to shed more light on this important issue! #Type1Diabetes #Tidepool

TIDE

ORG:TIDEPOOL

Tidepool